Hardy says Keytruda sales growth will moderate in 2026 ... Boston Scientific is a medical device manufacturer that specializes in cardiovascular, rhythm management and medical-surgical equipment.

President Trump wants to bring pharmaceutical manufacturing back to the U.S. Experts warn tariffs could result in shortages ...

LifeArc was entitled to royalties from Keytruda (pembrolizumab ... accelerate the development of new therapies, diagnostics and devices for those people in greatest need.” ...

Keytruda has been approved since 2016 as a second ... NHS England has started a pilot trial of an iPhone app and device combination that could be used by nursing staff to speed up reviews of ...

Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week. InvestingPro subscribers always get first dibs on market-moving AI analyst comments. Upgrade today! Super Micro ...

According to the private global space research and consulting firm Novaspace, a total of 1,842 satellites were launched into ...

Why ALZpath, GeneDX, 10x Genomics, Protagonist Therapeutics, and Recursion are among the most innovative biotech companies of 2025.

News Briefs - Nationwide Hospitals Warned of Potential Terror Threat - The American Hospital Association and the nonprofit Health-ISAC ...

Retail investors can respond indifferently to share purchase plans (SPPs), so it's heartening that 4D Medical's (ASX:4DX) ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

Learn more about whether Alvotech or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which ...